|Fastest Growing Market:||Asia-Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The dialysis concentrate market is projected to grow with a CAGR of 5.73% during the forecast period (2022 - 2027).
Coronavirus disease 2019 (COVID-19) has impacted the care and results of dialysis patients worldwide. SARS-CoV-2 infection and mortality are more common among dialysis patients, and many have experienced psychological anguish and delayed or poor care. According to an article published by the National Center for Biotechnology Information in 2022, titled " COVID-19 in dialysis: clinical impact, immune response, prevention and treatment", 15% to 20% excess mortality rates have been observed in patients on dialysis in the United States, in early 2020. According to a research article by Claudia Benedetti et al., published in Frontiers in Medicine Journal 2020, the study results indicate that patients with kidney disease could represent a risk factor in elderly patients for a more severe disease course. Furthermore, a research article by Meritxell Ibernon et al., published in Hemodialysis International Journal 2020, found that COVID-19 has shown a high incidence and mortality rate in hemodialysis patients. Thus, early preventive measures against COVID-19 could decrease the risk of spreading the disease in vulnerable patients.
The factors driving the growth of the dialysis concentrate market are the rising prevalence of kidney diseases such as end-stage renal disease (ESRD), acute kidney injury (AKI), shortage of organ donors, risks associated with transplants, technological advancements, and initiatives by the leading players to introduce advanced products and services. For instance, according to a research article by Pietro Ravani et al., published in JAMA Journal 2020, the study results found that the incidence rate of stage IV chronic kidney disease increased with age. For those 75 years and older, the risk of death was much higher than that of kidney failure. The high burden of chronic kidney disease is expected to boost the market, increasing the demand for renal dialysis and further increasing the demand for dialysis concentrates in the coming years. According to the study published by PlosOne, in 2022, titled " Prevalence of chronic kidney disease stages 3-5 in low-and middle-income countries in Asia: A systematic review and metanalysis", it has been found that the prevalence of chronic kidney disease stages 3-5 in low-and middle-income countries was 11.2%. In addition, the prevalence rate for chronic kidney disease in east Asia was 12%, 8.6% in east Asia, 12% in south-east Asia, 13.1% in western Asia, and 13.5% in South Asia.
Moreover, the mortality rate associated with chronic kidney diseases is increasing. For instance, according to the Centers for Disease Control, 2021, it has been found that Mississippi had the highest mortality rate for chronic kidney disease, in 2020, in the United States. However, the complications in dialysis treatment and reimbursement policy issues in growing countries could stifle the dialysis concentrate market's growth.
Scope of the Report
As per the scope of the report, dialysis concentrate comprises purified water, glucose, and electrolytes and is used in hemodialysis, where the solution is created according to the requirement and aids in electrolyte regulation and the removal of metabolic waste products. The Global Dialysis Concentrate Market is segmented by Type (Acid Concentrates, Bicarbonate Concentrates, and Peritoneal Dialysis Fluid), Applications (Hemodialysis and Peritoneal Dialysis), Dialysis site (Hospital, Clinics & Dialysis Centers, and Home Dialysis) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.
|Peritoneal Dialysis Fluid|
|By Dialysis Site|
|Clinics & Dialysis Centers|
Key Market Trends
Hemodialysis Segment Expects to Drive the Market Growth
The factors driving the growth of the hemodialysis segment are increasing incidences of hypertension and diabetes, which leads to kidney failure, a rising number of patients with kidney disease, and a shortage in the availability of kidneys for transplants.
The rising number of geriatric population suffering from kidney diseases will likely boost the demand for the hemodialysis segment over the forecast period. According to the statistics published by the Centers for Disease Control, in 2021, 38% of people aged 65 years or older are at high risk of developing chronic kidney disease, 12% in people 45-64 years of age, and 6% in people aged 18-44 years.
Additionally, various technological innovations, government initiatives, and the introduction of compact-sized machines that can be conveniently used for home-based treatments significantly boost the demand for the hemodialysis segment. For instance, in March 2022, in India, Safdarjung Hospital set up a new unit with two hemodiafiltrations (HDF) machines, which help patients better purify kidneys during dialysis. In December 2020, Medtronic launched a dialysis machine for neonatal and pediatrics in the United States. Similarly, in October 2020, the United States-based privately held medical device company, Diality, invested around USD 12.5 million in developing a portable hemodialysis system to address the unmet technology needs of the evolving dialysis industry. Thus, the high burden of kidney disease is increasing the demand for hemodialysis, thereby contributing to the market's growth.
To understand key trends, Download Sample Report
North America is Expected to Have the Significant Market Share
The rising incidence of kidney diseases such as end-stage renal disorder (ESRD), chronic kidney disease, and acute kidney injury are expected to drive the demand for hemodialysis. According to the statistics published by the National Institute of Diabetes and Digestive and Kidney Diseases, in 2021, about 786,000 people in the United States are living with an end-stage renal disorder (ESRD), with 71% of the people are on dialysis, and 29% with a kidney transplant. According to the same source, nearly 500,000 Americans are affected by polycystic kidney disease (PKD), an inherited kidney disorder. According to the United States Organ Procurement and Transplantation Network, 2020, 22,817 kidney transplants were completed in the United States. In addition, 90,201 people were on the waiting list for a kidney transplant in the United States as of August 2021.
The incidence of chronic kidney disease is more common in females than males. According to the statistics published by the Centers for Disease Control, in 2021, 15% of adults in the United States are expected to have chronic kidney disease. In addition, slightly more common in women (14%) than men (12%).
The survival rates of dialysis patients are decreased by 70% more than a normal person. According to a study published in Canadian Medical Association Journal (CMAJ), in 2021, the patients on long-term dialysis were about four times more likely to die than the general population and almost five times more likely to become infected with COVID-19.
Moreover, the research development initiatives and development of machines with advanced technology are also contributing to the growth of hemodialysis, further increasing the demand for dialysis concentrate in the region. For instance, in December 2020, Medtronic launched a dialysis machine for neonatal and pediatrics in the United States.
Thus, growing kidney disease cases and increasing development in the dialysis segment in the region are expected to boost the dialysis concentrates market growth in the coming years.
To understand geography trends, Download Sample Report
The dialysis concentrate market is fragmented and highly competitive, with many players. The companies are adopting various business strategies such as expanding collaborations, partnerships, and acquisitions to retain their market position. Some key players include Fresenius Medical care, Baxter International Inc., B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd, and Rockwell Medical.
In April 2022, Rockwell Medical, Inc. announced an expanded partnership with DaVita Inc. to revise certain terms of its supply contracts with customers to stabilize its concentrates business.
In June 2021, Rockwell Medical, Inc. announced that it extended its distribution agreement with Nipro Medical Corporation for three years through May 2024. With the extension of the agreement, Nipro Medical Corporation will continue to distribute dialysis concentrates manufactured by Rockwell Medical to numerous countries in Latin America and the Caribbean.
In January 2021, D.med and Inspramed entered into an agreement under which D.med acquired 100 percent of the shares of Inspramed. Inspramed manufactures dialysis consumables producing acid/basic concentrates, bicarbonate cartridges/bags, and disinfectants suitable for all common dialysis machines.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Kidney Diseases and Acute Kidney Injury
4.2.2 Increasing Investment in Research and Development
4.3 Market Restraints
4.3.1 Growing Concerns Regarding Reimbursement Policy and Treatment Complications
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 Acid Concentrates
5.1.2 Bicarbonate Concentrates
5.1.3 Peritoneal Dialysis Fluid
5.2 By Application
5.2.2 Peritoneal Dialysis
5.3 By Dialysis Site
5.3.2 Clinics & Dialysis Centers
5.3.3 Home Dialysis
5.4.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle-East and Africa
5.4.5 South America
126.96.36.199 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Fresenius Medical Care
6.1.2 Baxter International Inc.
6.1.3 B. Braun Melsungen AG
6.1.4 Rockwell Medical
6.1.5 MEDIVATORS Inc.
6.1.6 Dialysis Medical Solutions
6.1.9 Nipro Renal Solutions
6.1.10 Browndove Healthcare Pvt Ltd
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Dialysis Concentrate Market market is studied from 2019 - 2027.
What is the growth rate of Global Dialysis Concentrate Market?
The Global Dialysis Concentrate Market is growing at a CAGR of 5.73% over the next 5 years.
Which region has highest growth rate in Global Dialysis Concentrate Market?
Asia-Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Dialysis Concentrate Market?
North America holds highest share in 2021.
Who are the key players in Global Dialysis Concentrate Market?
Fresenius Medical Care, Baxter International Inc., B. Braun Melsungen AG, Rockwell Medical, Nipro Renal Solutions are the major companies operating in Global Dialysis Concentrate Market.